Every 2 Weeks or Every 4 Weeks Subcutaneous Injection of Emicizumab in Pediatric Patients with Severe Hemophilia a without Inhibitors: A Multi-Center, Open-Label Study in Japan (HOHOEMI Study)

被引：7

作者：

Shima, Midori ^{[1
]}

Nogami, Keiji ^{[1
]}

Nagami, Sayaka ^{[2
]}

Yoshida, Seitaro ^{[2
]}

Yoneyama, Koichiro ^{[2
]}

Ishiguro, Akira ^{[3
]}

Suzuki, Takashi ^{[4
]}

Taki, Masashi ^{[5
]}

机构：

[1] Nara Med Univ, Dept Pediat, Kashihara, Nara, Japan

[2] Chugai Pharmaceut Co Ltd, Tokyo, Japan

[3] Natl Ctr Child Hlth & Dev, Div Hematol, Tokyo, Japan

[4] Ogikubo Hosp, Dept Blood Coagulat, Tokyo, Japan

[5] St Marianna Univ, Dept Pediat, Sch Med, Kawasaki, Kanagawa, Japan

来源：

关键词：

D O I：

10.1182/blood-2018-99-115792

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1186

引用

页数：2